RNN may see a bottom bounce and some retracement after its announcement of a 1-10 share reversal. If not, buy the dips. Appears Mgt. has confidence in drug trials and is looking to gain Institutional support by increasing share price. IMHO
(0)
(0)
'Everything works out in the end,,,If it hasn't worked out,,it's not the end'